INIS
risks
100%
pediatrics
100%
failures
100%
liver
100%
mortality
25%
patients
16%
organs
16%
children
16%
blood
16%
creatinine
16%
aminotransferases
16%
therapy
8%
hospitals
8%
adults
8%
comparative evaluations
8%
units
8%
reviews
8%
length
8%
kidneys
8%
ventilation
8%
Medicine and Dentistry
Acute on Chronic Liver Failure
100%
Pediatrics
100%
Mortality
25%
Development
16%
Creatinine
16%
Aspartate Aminotransferase
16%
Blood Culture
16%
Decompensated Liver Cirrhosis
16%
Patient
16%
Child
16%
Prevalence
8%
Diagnosis
8%
Artificial Respiration
8%
Multiple Organ Dysfunction Syndrome
8%
Respiratory Failure
8%
Biliary Atresia
8%
Liver Transplantation
8%
Hepatic Encephalopathy
8%
Mixed Model
8%
Age
8%
Renal Replacement Therapy
8%
Hospital
8%
Adult
8%
Medication
8%
Intensive Care Unit
8%
Organ
8%
Nursing and Health Professions
Acute on Chronic Liver Failure
100%
Pediatrics
100%
Hospitalization
41%
Mortality
25%
Blood Culture
16%
Creatinine
16%
Decompensated Liver Cirrhosis
16%
Aspartate Aminotransferase
16%
Length of Stay
8%
Pediatric Hospital
8%
Intensive Care Unit
8%
Prevalence
8%
Drug Therapy
8%
Artificial Respiration
8%
Diagnosis
8%
Bile Duct Atresia
8%
Renal Replacement Therapy
8%
Liver Transplantation
8%
Hepatic Encephalopathy
8%
Respiratory Failure
8%
Multiple Organ Failure
8%
Pharmacology, Toxicology and Pharmaceutical Science
Acute on Chronic Liver Failure
100%
Mortality
25%
Creatinine
16%
Aspartate Aminotransferase
16%
Decompensated Liver Cirrhosis
16%
Multiple Organ Failure
8%
Prevalence
8%
Hepatic Encephalopathy
8%
Respiratory Failure
8%
Bile Duct Atresia
8%
Replacement Therapy
8%